However, a significant association was observed between carrying the −64I allele of CCR2-64I gene polymorphism and higher susceptibility to NSCLC in a Tunisian population, with a higher expression of CCR2 in patients (Rafrafi et al., 2015). The gene discussed is CCR2; the disease is non-small cell lung carcinoma.